Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Galit Alter, Ph.D.

Co-Author

This page shows the publications co-authored by Galit Alter and Yannic Bartsch.
Connection Strength

2.761
  1. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021 02 15; 12(1):1018.
    View in: PubMed
    Score: 0.961
  2. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
    View in: PubMed
    Score: 0.960
  3. Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19. bioRxiv. 2021 May 12.
    View in: PubMed
    Score: 0.244
  4. Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features. mBio. 2021 03 09; 12(2).
    View in: PubMed
    Score: 0.241
  5. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021 07 15; 131(14).
    View in: PubMed
    Score: 0.062
  6. Epidemiological and immunological features of obesity and SARS-CoV-2. medRxiv. 2020 Dec 11.
    View in: PubMed
    Score: 0.059
  7. Reply. J Pediatr. 2021 01; 228:317-319.
    View in: PubMed
    Score: 0.058
  8. Reply. J Pediatr. 2021 01; 228:320-323.
    View in: PubMed
    Score: 0.058
  9. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J Pediatr. 2020 12; 227:45-52.e5.
    View in: PubMed
    Score: 0.058
  10. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19. Cell. 2020 10 01; 183(1):143-157.e13.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.